Posted 12 December 2017
NHS England has decided to stop covering 18 “low value” treatments, a move the government believes will generate £141 million in annual savings. The list includes seven that have also also been referred to the Department of Health for blacklisting: homeopathy, herbal treatments, omega-3 fatty acid compounds (fish oil), co-proxamol, rubefacients (excluding topical NSAIDS), lutein and antioxidants, and glucosamine and chondroitin.
[Items which should not be routinely prescribed in primary care: Consultation and Report of Findings. NHS England, Nov 30, 2017] https://www.england.nhs.uk/wp-content/uploads/2017/11/items-which-should-not-be-routinely-precscribed-in-pc-consultation-report.pdf… Read the rest